ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Rare Lung Disease Raises Risk Of Meningiomas

October 26, 2001

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

Grand Jury Clears Eppley, Shubik

October 24, 1980